Cargando…

Efficacy and safety of bifid triple viable plus aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis

OBJECTIVE: Ulcerative colitis (UC), one of the most stubborn diseases, is mainly treated by aminosalicylic acid (ASA). However, the side effects of ASA include vomiting, nausea, rash, diarrhea, headache, etc, which seriously affect life-quality of UC patients. Probiotics such as bifid triple viable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mu-yuan, Qiu, Zhen-wen, Tang, Hong-mei, Zhuang, Kun-hai, Cai, Qing-qun, Chen, Xin-lin, Li, Hui-biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882635/ https://www.ncbi.nlm.nih.gov/pubmed/31764796 http://dx.doi.org/10.1097/MD.0000000000017955

Ejemplares similares

The Effect of Bifid Triple Viable on Immune Function of Patients with Ulcerative Colitis
por: Li, Guohua, et al.
Publicado: (2012)

Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients
por: Li, Shuying, et al.
Publicado: (2021)

Efficacy and safety of Kangfuxin liquid combined with aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis
por: Li, Hui-biao, et al.
Publicado: (2018)

Influences of Bifid Triple Viable Capsules Plus Cetirizine on Gut Microbiota and Immune Function in Children with Eczema
por: Su, Zhenxing, et al.
Publicado: (2022)

Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
por: Jiang, Wenyu, et al.
Publicado: (2023)

The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023)

Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies
por: Nie, Jia-Yan, et al.
Publicado: (2017)

Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study
por: Chen, De-Liang, et al.
Publicado: (2021)

Endocytoscopic classification can be predictive for relapse in ulcerative colitis
por: Ueda, Naoki, et al.
Publicado: (2018)

Ulcerative colitis and thrombocytosis: Case report and literature review
por: Zhou, Yaqi, et al.
Publicado: (2023)

5-Aminosalicylic acid for treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis
por: Cheng, Wenyuan, et al.
Publicado: (2020)

Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
por: Yu, Yunfeng, et al.
Publicado: (2022)

Lymphocyte infiltration and key differentially expressed genes in the ulcerative colitis
por: Zhang, Junhui, et al.
Publicado: (2020)

Pathological mechanism and targeted drugs of ulcerative colitis: A review
por: Guo, Meitong, et al.
Publicado: (2023)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
por: Jeong, Yo Han, et al.
Publicado: (2017)

Ulcerative colitis with acute pleurisy: A case report and review of the literature
por: Lu, Shuming, et al.
Publicado: (2017)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis
por: Uygun, Ahmet, et al.
Publicado: (2017)

Ustekinumab is effective against ulcerative colitis with intestinal stenosis: A case report
por: Liu, Ailing, et al.
Publicado: (2022)

Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)

Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report
por: Zhu, Zhenhua, et al.
Publicado: (2018)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Intestinal flora differences between patients with ulcerative colitis of different ethnic groups in China
por: Liu, Huan, et al.
Publicado: (2021)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis in a young patient with ulcerative colitis: A case report
por: Deskur, Anna, et al.
Publicado: (2019)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values
por: Zou, Menglong, et al.
Publicado: (2023)

Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis
por: Gao, Jie, et al.
Publicado: (2023)

Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Sun, Dali, et al.
Publicado: (2016)

Huang Lian for ulcerative colitis: A protocol of systematic review and meta-analysis of randomized clinical trials
por: Li, Tinglin, et al.
Publicado: (2020)

Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab: A case report
por: Kakiuchi, Toshihiko, et al.
Publicado: (2022)

Comparative study between histochemical mucus volume, histopathological findings, and endocytoscopic scores in patients with ulcerative colitis
por: Kamitani, Yu, et al.
Publicado: (2023)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n5ldejek3euhivthvb1uumsd7b